1-12 of 12
Karina Eiwen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aged murine hematopoietic stem cells drive aging-associated immune remodeling

Hanna Leins, Medhanie Mulaw, Karina Eiwen, Vadim Sakk, Ying Liang, Michael Denkinger, Hartmut Geiger, Reinhold Schirmbeck
Journal: Blood
Blood (2018) 132 (6): 565–576.
https://doi.org/10.1182/blood-2018-02-831065
Published: 2018
Includes: Supplemental data
Journal Articles

Minimal Residual Disease (MRD) Monitoring in NPM1 Mutated Acute Myeloid Leukemia (AML): Impact of Concurrent FLT3 -ITD and DNMT3A Mutations on MRD Kinetics and Clinical Outcome

Silke Kapp-Schwoerer, Jan Krönke, MD, Andrea Corbacioglu, PhD, Verena I. Gaidzik, MD, Peter Paschka, MD, Karina Eiwen, Daniela Späth, MSc, Gudrun Göhring, MD, Brigitte Schlegelberger, MD, PhD, Michael Lübbert, MD, Thomas Kindler, MD, Mohammed Wattad, MD, Ulrich Germing, MD, David Nachbaur, MD, Walter Fiedler, MD, Felicitas Thol, MD, Michael Heuser, MD, Jürgen Krauter, MD, Arnold Ganser, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 2555.
https://doi.org/10.1182/blood.V122.21.2555.2555
Published: 2013
Journal Articles

Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL -Rearranged Acute Myeloid Leukemias

Gröschel Stefan, MD, Richard F. Schlenk, MD, Karina Eiwen, Jan Engelmann, Michael Luebbert, Ulrich Germing, MD, Ingo Schmidt-Wolf, MD, Brigitte Schlegelberger, MD, Jürgen Krauter, MD, Arnold Ganser, MD, Ruud Delwel, Ph.D., Bob Lowenberg, MD, PhD, Konstanze Döhner, Hartmut Döhner, MD
Journal: Blood
Blood (2011) 118 (21): 1441.
https://doi.org/10.1182/blood.V118.21.1441.1441
Published: 2011
Journal Articles

Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG.

Verena I. Gaidzik, M.D., Cailian Wang, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Peter Paschka, M.D., Frank G. Rücker, M.D., Andrea Corbacioglu, Ph.D., Karina Eiwen, Jürgen Krauter, M.D., Brigitte Schlegelberger, MD, Arnold Ganser, M.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Hartmut Döhner, M.D., Konstanze Döhner, M.D.
Journal: Blood
Blood (2009) 114 (22): 1600.
https://doi.org/10.1182/blood.V114.22.1600.1600
Published: 2009
Journal Articles

Identification of Clinically Relevant Predictive MRD Checkpoints in AML Patients with NPM1 Mutations: A Study of the AML Study Group (AMLSG).

Jan Krönke, Richard Schlenk, Kai-Ole Jensen, Karina Eiwen, Marianne Habdank, Daniela Späth, Jürgen Krauter, Arnold Ganser, Prof./M.D., Gudrun Göhring, MD, Brigitte Schlegelberger, MD, Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2009) 114 (22): 1586.
https://doi.org/10.1182/blood.V114.22.1586.1586
Published: 2009
Journal Articles

High EVI1 Expression Predicts Outcome in Younger Adult (15 to 60 years) Patients with Acute Myeloid Leukemia and Is Associated with Distinctive Cytogenetic Subgroups.

Gröschel Stefan, Sanne Lugthart, Richard Schlenk, Peter Valk, Karina Eiwen, Chantal Goudswaard, Willem JL Van Putten, Sabine Kayser, Leo Verdonck, Michael Lübbert, Gert Ossenkoppele, Ulrich Germing, Ingo Schmidt-Wolf, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Bob Löwenberg, Konstanze Döhner, Ruud Delwel
Journal: Blood
Blood (2009) 114 (22): 582.
https://doi.org/10.1182/blood.V114.22.582.582
Published: 2009
Journal Articles

Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)

Jan Krönke, Richard Schlenk, Kai-Ole Jensen, Karina Eiwen, Marianne Habdank, Daniela Späth, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2008) 112 (11): 699.
https://doi.org/10.1182/blood.V112.11.699.699
Published: 2008
Journal Articles

Prognostic Impact of BAALC Expression in the Context of Other Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia.

Konstanze Dohner, MD, Andrea Corbacioglu, PhD, Karina Eiwen, Judith Ewert, Stefan Frohling, MD, Lars Bullinger, MD, Juergen Krauter, MD, Brigitte Schlegelberger, MD, Arnold Ganser, MD, Hartmut Dohner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2007) 110 (11): 3485.
https://doi.org/10.1182/blood.V110.11.3485.3485
Published: 2007
Journal Articles

CEBPA Germline Mutation Screening in Cytogenetically Normal Acute Myeloid Leukemia with Somatically Acquired CEBPA Mutations.

Andrea Corbacioglu, PhD, Stefan Fröhling, MD, Corinna Mendla, Karina Eiwen, Marianne Habdank, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2007) 110 (11): 363.
https://doi.org/10.1182/blood.V110.11.363.363
Published: 2007
Journal Articles

Aberrant Expression of the Homeobox Gene CDX2 in Acute Myeloid Leukemia.

Claudia Scholl, MD, Dimple Bansal, Ph.D., Konstanze Dohner, M.D., Karina Eiwen, Benjamin H. Lee, M.D., Ph.D., Frank G. Rucker, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Hartmut Dohner, M.D., D. Gary Gilliland, M.D., Ph.D., Stefan Frohling, M.D.
Journal: Blood
Blood (2006) 108 (11): 8.
https://doi.org/10.1182/blood.V108.11.8.8
Published: 2006
Journal Articles

Minimal Residual Disease (MRD) Monitoring in CBFB-MYH11 Acute Myeloid Leukemia (AML) Is of Prognostic Relevance for Relapse-Free Survival.

Andrea Corbacioglu, PhD, Claudia Scholl, MD, Karina Eiwen, Lars Bullinger, MD, Stefan Frohling, MD, Hartmut Dohner, MD, Richard F. Schlenk, MD, Konstanze Dohner, MD
Journal: Blood
Blood (2006) 108 (11): 2298.
https://doi.org/10.1182/blood.V108.11.2298.2298
Published: 2006
Journal Articles

MLL/AF9 Fusion Transcript Quantification in t(9;11)-Positive AML Identify Patients with High Risk of Relapse.

Claudia Scholl, MD, Karina Eiwen, Stefan Frohling, MD, Richard F. Schlenk, MD, Hartmut Dohner, MD, Konstanze Dohner, MD
Journal: Blood
Blood (2004) 104 (11): 3015.
https://doi.org/10.1182/blood.V104.11.3015.3015
Published: 2004